N Novartis
Updates & Highlights
Chosunbiz · about 1 month ago
Samsung Bioepis battles Janssen, Pfizer, Novartis in global biosimilar suits - CHOSUNBIZ
simplywall.st · about 1 month ago
Novartis (SWX:NOVN) FDA Approval Puts Pluvicto Value Story Back In Focus
Novartis · about 1 month ago
Novartis marks 30 years of breakthroughs, building on 250 years of discovery to reimagine what medicine can do next
Recent Openings
View all 2 jobs arrow_forwardAll Jobs
Culture & Mission
Benefits & Perks
Equity/Stock Options
Ownership in the company
Health Insurance
Medical, dental & vision
Remote Work
Work from anywhere flexibility
Learning Budget
Professional development
Generous PTO
Paid time off
401(k) Match
Retirement savings
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Novartis?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company arrow_forwardNews & Press
20 recentSamsung Bioepis battles Janssen, Pfizer, Novartis in global biosimilar suits - CHOSUNBIZ
Samsung Bioepis battles Janssen, Pfizer, Novartis in global biosimilar suits - CHOSUNBIZ
Chosunbiz · about 1 month ago
Novartis (SWX:NOVN) FDA Approval Puts Pluvicto Value Story Back In Focus
Novartis (SWX:NOVN) FDA Approval Puts Pluvicto Value Story Back In Focus
simplywall.st · about 1 month ago
Novartis marks 30 years of breakthroughs, building on 250 years of discovery to reimagine what medicine can do next
Novartis marks 30 years of breakthroughs, building on 250 years of discovery to reimagine what medicine can do next
Novartis · about 1 month ago
Patrick Soon-Shiong: Great to See That Novartis Drug With Lu177 Received Expanded Approval
Patrick Soon-Shiong: Great to See That Novartis Drug With Lu177 Received Expanded Approval
Oncodaily · about 1 month ago
Novartis Enrolled First Participant in Phase 3 PRESERVE Clinical Trial for Experimental PSP-RS Treatment - AFTD
Novartis Enrolled First Participant in Phase 3 PRESERVE Clinical Trial for Experimental PSP-RS Treatment - AFTD
The Association for Frontotemporal Degeneration · about 1 month ago
Research Analysts Offer Predictions for Novartis Q3 Earnings
Research Analysts Offer Predictions for Novartis Q3 Earnings
MarketBeat · about 1 month ago
Recon: AstraZeneca, BMS discuss merger; FDA broadens indication for Novartis’ Pluvicto
Recon: AstraZeneca, BMS discuss merger; FDA broadens indication for Novartis’ Pluvicto
RAPS · about 1 month ago
Novartis' Pluvicto leaps ahead into earlier manifestation of prostate cancer
Novartis' Pluvicto leaps ahead into earlier manifestation of prostate cancer
Fierce Pharma · about 1 month ago
Processa Acquisition Lands Immunology Drug That Could Rival a New Novartis Product
Processa Acquisition Lands Immunology Drug That Could Rival a New Novartis Product
MedCity News · about 1 month ago
Novartis (NYSE:NVS): A Top Dividend Stock with Strong Fundamentals and Sustainable Payouts
Novartis (NYSE:NVS): A Top Dividend Stock with Strong Fundamentals and Sustainable Payouts
ChartMill · about 1 month ago
Novartis chart may soon 'complete a well-defined bullish reversal,' Cappelleri says
Novartis chart may soon 'complete a well-defined bullish reversal,' Cappelleri says
CNBC · about 1 month ago
Denise Campbell of Novartis on the Shifting Conversations in Healthcare
Denise Campbell of Novartis on the Shifting Conversations in Healthcare
Muse by Clio · about 1 month ago
Novartis AG (NVS) Stock Forecasts
Novartis AG (NVS) Stock Forecasts
Yahoo Finance · about 1 month ago
NOVARTIS AG : Berenberg remains Neutral
NOVARTIS AG : Berenberg remains Neutral
marketscreener.com · about 1 month ago
Chinese Pharma Contractor Porton Scraps European Expansion After Novartis Dispute
Chinese Pharma Contractor Porton Scraps European Expansion After Novartis Dispute
Caixin Global · about 1 month ago
Weekly Recap: Novartis Q2 net sales up ~1–3% and Entresto 50% sales drop
Weekly Recap: Novartis Q2 net sales up ~1–3% and Entresto 50% sales drop
TradingView · about 2 months ago
Anthropic’s life science plans; Novartis CEO on China deals; and more
Anthropic’s life science plans; Novartis CEO on China deals; and more
Endpoints News · about 2 months ago
How Novartis R&D is advancing the next breakthrough innovations
How Novartis R&D is advancing the next breakthrough innovations
Novartis · about 2 months ago
Big Pharma Is Buying Growth. Novartis (NVS) Is Betting on Its Pipeline
Big Pharma Is Buying Growth. Novartis (NVS) Is Betting on Its Pipeline
Yahoo Finance · about 2 months ago
Novartis scraps mid-stage radiopharma asset as Pluvicto soars
Novartis scraps mid-stage radiopharma asset as Pluvicto soars
BioSpace · about 2 months ago